ChinaBio Executive Workshop: Building Company Value Through Global Partnerships

Building intellectual asset value within collaboration
- Understanding the differences between China and Western la
- Capturing the value of joint innovation
- Building and managing an international patent portfolio cost-effectively
- Harmonizing the partnership’s IPR strategy with its business plan
- Avoiding pitfalls in licensing and collaborative transaction

Finding and keeping suitable global partners
- Positioning your business and IP portfolio with potential partners and investors
- Using best practices for successful joint ventures and strategic partnerships
- Negotiating with Americans: Chinese vs. American negotiation approaches
- Resolving disagreements between partners
- Leveraging private and government funding sources within and outside of China

The state of China’s biotech industry
- China’s life science industry is moving quickly from services to innovation. Hear the latest update on novel technology development, investment, M&A and partnering deals, IPOs, and other data from ChinaBio’s research team.

This program included key life sciences executives and investors interested in learning how to secure and manage global partnerships, raise funding, and generate global intellectual property rights. Attendees learned “how to do it” from our speakers who have successfully put their principles into practice in the real world.

Speakers:

Stephen A. Bent, Foley Partner and member of the firm’s Chemical, Biotechnology & Pharmaceutical Practice and Health Care and Nanotechnology Industry Teams
James C. Chapman, Foley Partner and member of the firm’s Private Equity & Venture Capital Practice and Emerging Technologies Industry Team
James F. Ewing, Foley Partner, Vice Chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice, and member of the Life Sciences, Food, and Nanotechnology Industry Teams
Greg B. Scott, President and founder, ChinaBio Accelerator